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Introduction: Reliable methods for short term blood glucose level prediction can be effi-
ciently integrated into mobile Ambient Assisted Living (AAL) services for diabetes manage-
ment. Subcutaneous insulin absorption is one of the key factors beside the meal consumed and
the blood glucose history values that such prediction methods must consider. According to the
current practice, insulin dependent diabetic patients use a basal or long-acting insulin injection
once a day that produces a steady insulin level for the whole day, and bolus injections for every
meal in order to control their blood glucose. The mathematical models commonly used blood
glucose prediction can handle only bolus insulin in a correct way, which makes effective only
for inpatient care. One can simulate the effect of the basal insulin as a single injection of bolus
insulin with a slowly rising curve with a very high maximum value. However, in reality the
basal insulin level reaches a proper level in a very short time and the effect lasts for a long time.
An adjustment to the model is required to properly handle basal insulin in order to reach more
accurate results. By substituting the single big dose of basal insulin with a series of smaller
bolus insulin doses we can carry out the steady curve of insulin presence in the blood similar
to the curve defined by the medicine manufacturers.
Method: We implemented our blood glucose prediction model [1] by combining two state-
of-the-art models. The first one models the glucose absorption in two compartments (stomach
and intestines) [2]. This model can manage various sorts of food with different glycemic indices
and it can also handle the overlap of meals. The other model is based on nonlinear discrete-
delay differential equations [3], and it model the blood glucose and insulin control system.
The equations of the model describe insulin transfer between subcutaneous insulin depots,
insulin absorption into blood and the role of insulin in blood glucose control. In our proposed
method, we model the long-acting insulin in a correct way by using a series of smaller insulin
doses, instead of one big dose, the original time interval divided into short subintervals with
low maximal absorption time (Tmax). We tested the method on a data set of a clinical trial in
which 16 insulin dependent patients (7 female and 9 male) used a Continuous Glucose Monitor
(CGM) device to record their blood glucose levels for six days, while their meals were recorded.
In order to test the proposed method, we used 4 profiles of basal insulins, each profile having
a specific number of doses, dose amounts, injection times and Tmax values, thus simulating
the original basal insulin injection. We applied the original model and the corrected model
to predict short term (180 mins) blood glucose levels with various basal insulin profiles and
computed the average absolute error of the prediction compared to the CGM records.
Results: The average improvement achieved by the correction was 0.63 mmol/l and the
biggest improvement was 2.37 mmol/l. In some special cases the average error increased due
to the improved basal insulin model (in case of Lantus and Levemir insulins). Table I show the
results.
TABLE I. Average improvement, Biggest improvement and Worse results data for each insulin
profile
We also analyzed the prediction accuracy at the next meal time. A frequently used measure
in the literature is the ratio of error, i.e. the rate of prediction errors less than 3 mmol/l. We
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can state that in 5 cases more than 50% of the errors were within 3 mmol/l, in 11 cases it was
between 30% and 50%. In two cases, it failed to achieve an acceptable result. Figure I shows
results of two day’s test for P11 patient.
FIGURE I. Prediction of Blood Glucose Level at the next meal time for P11 patient.
Conclusion: It is difficult to compare our results for long-acting insulin management in
blood glucose prediction with the literature because to our best knowledge no research has
been published in exactly this field so far.
Our results without correction were not far from the best results published [4]. The aver-
age improvement of more than 0.6 mmol/l earned by the correction is remarkable. This im-
provement, combined with the expected improvement from the planned management of other
factors like stress, insulin sensitivity and physical activity, could make our prediction model
more efficient and reliable as a module of the Lavinia lifestyle mirror mobile application [5] for
outpatient healthcare.
References
[1] P. Gyuk, T. Lorincz, Rebaz A. H. K., I. Vassanyi. Diabetes Lifestyle Support with Improved Glycemia
Prediction Algorithm. Telemedicine, and Social Medicine (eTELEMED 2015), ISBN 978-1-61208-384-
1, Lisboa, Portugal, 22-27 February 2015, pp. 95-100.
[2] T. Arleth, S. Andreassen, M. Orsini-Federici, A. Timi, and M. Massi-Benedetti,
Optimisation of a model of glucose absorption from mixed meals, 2005.
http://www.mmds.aau.dk/Publikationer/DIAS/optimisation of a model of glucose absorp-
tion from mixed meals.pdf
[3] P. Palumbo, P. Pepe, S. Panunzi, and A. De Gaetano. Glucose control by subcutaneous insulin ad-
ministration: a DDE modelling approach, in Proc. 18th IFAC World Congress, Milan, Italy, 2011, pp.
1471-1476
[4] R. A. H. Karim, P. Gyuk, T. Lorincz, I. Vassanyi, I. Kosa. Blood Glucose Level Prediction for Mobile
Lifestyle Counseling. Med-e-Tel2015, Int. Conf. of the International Society for Telemedicine and
eHealth, 22-24 April 2015, Luxembourg. Knowledge Resources, Vol 8 (2015), ISSN 1998-5509, pp.
8-12.
[5] I. Kosa, I. Vassanyi, M. Nemes, K.H. Kalmanne, B. Pinter, and L. Kohut, A fast, android based dietary
logging application to support the life change of cardio-metabolic patients, Global Telemedicine and
eHealth Updates: Knowledge Resources, 7, 2014, pp. 553-556 http://www.lavinia.hu/.
54
